Form S-3 SAB Biotherapeutics,
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/24/2026
- Wall Street ends down as oil prices, Treasury yields rise
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil settles up around 4% as Iran's president vows to never surrender
- Wall Street ends down as oil prices, Treasury yields rise
- Anthropic's Claude AI identifies novel enzyme system in DNA search
- AppLovin (APP) on watch amid 3% drop premarket as boutique comments circulate
- Plug Power COO resigns to join another company
- Xtend AI Robotics wins Phase III of USSOCOM lethal drone program
SAB Biotherapeutics (SABS) files $300M mixed shelf
December 30, 2025 10:11 AM ESTSAB Biotherapeutics (NASDAQ: SABS) has filed $300,000,000 mixed shelf of:
Common Stock
Preferred Stock
Debt Securities
Warrants
Rights
Units
... More